Trials / Completed
CompletedNCT02153372
Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial
Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Goethe University · Academic / Other
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
In the present phase-I clinical trial we investigate safety and feasibility of an augmentation with preoperatively isolated autologous BMC cells seeded onto ß-TCP in combination with an angle stable fixation (Philos plate®) for the therapy of proximal humeral fractures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | BMC2012 |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-06-03
- Last updated
- 2016-05-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02153372. Inclusion in this directory is not an endorsement.